Top

Published in:

01-08-2007 | Letter to the Editor

Plasmablastic lymphoma of visceral cranium, cervix and thorax in an HIV-negative woman

Authors: Aikaterini Masgala, Constantinos Christopoulos, Niki Giannakou, Haralambos Boukis, Theodora Papadaki, Eleftherios Anevlavis

Published in: Annals of Hematology | Issue 8/2007

Excerpt

Dear Editor, …

Banks PM, Keller RH, Li CY, White WL (1978) Malignant lymphoma of plasmablastic identity. A neoplasm with both “immunoblastic” and plasma cellular features. Am J Med 64(5):906–909PubMedCrossRef

Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U et al (1997) Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 89(4):1413–1420PubMed

Teruya-Feldstein J, Chiao E, Filippa DA, Lin O, Comenzo R, Coleman M et al (2004) CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 15(11):1673–1679PubMedCrossRef

Colomo L, Loong F, Rives S, Pittaluga S, Martinez A, Lopez-Guillermo A et al (2004) Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 28(6):736–747PubMedCrossRef

Cioc AM, Allen C, Kalmar JR, Suster S, Baiocchi R, Nuovo GJ (2004) Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol 28(1):41–46PubMedCrossRef

Deloose ST, Smit LA, Pals FT, Kersten MJ, van Noesel CJ, Pals ST (2005) High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma. Leukemia 19(5):851–855PubMedCrossRef

Vega F, Chang CC, Medeiros LJ, Udden MM, Cho-Vega JH, Lau CC et al (2005) Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol 18(6):806–815PubMedCrossRef

Brugiere O, Pialoux G, Carnot F, Pol S (1996) Primary non-Hodgkin’s lymphomas of the liver in human immunodeficiency virus infected patients. Three cases. Gastroenterol Clin Biol 20:307–311PubMed

Dales JP, Harket A, Bagneres D, Andrac-Meyer L, Xerri L, Frances Y et al (2005) Plasmablastic lymphoma in a patient with HIV infection: an unusual case located in the skin. Ann Pathol 25(1):45–49PubMed

10.

Lin F, Zhang K, Quiery AT Jr, Prichard J, Schuerch C (2004) Plasmablastic lymphoma of the cervical lymph nodes in a human immunodeficiency virus-negative patient: a case report and review of the literature. Arch Pathol Lab Med 128(5):581–584PubMed

11.

Lin Y, Rodrigues GD, Turner JF, Vasef MA (2001) Plasmablastic lymphoma of the lung: report of a unique case and review of the literature. Arch Pathol Lab Med 125(2):282–285PubMed

12.

Nguyen DD, Loo BW Jr, Tillman G, Natkunam Y, Cao TM, Vaughan W et al (2003) Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. Ann Hematol 82(8):521–525PubMedCrossRef

13.

Nicol I, Boye T, Carsuzaa F, Feier L, Collet Villette AM, Xerri L et al (2003) Post-transplant plasmablastic lymphoma of the skin. Br J Dermatol 149(4):889–891PubMedCrossRef

14.

Pruneri G, Graziadei G, Ermellino L, Baldini L, Neri A, Buffa R (1998) Plasmablastic lymphoma of the stomach. A case report. Haematologica 83(1):87–89PubMed

15.

Schichman SA, McClure R, Schaefer RF, Mehta P (2004) HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: a further expansion of the disease spectrum. Am J Hematol 77(3):291–295PubMedCrossRef

16.

Carbone A, Gloghini A, Larocca LM, Capello D, Pierconti F, Canzonieri V et al (2001) Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood 97(3):744–751PubMedCrossRef

17.

Brown RS, Power DA, Spittle HF, Lankester KJ (2000) Absence of immunohistochemical evidence for human herpesvirus 8 (HHV8) in oral cavity plasmablastic lymphoma in an HIV-positive man. Clin Oncol (R Coll Radiol) 12(3):194

Title: Plasmablastic lymphoma of visceral cranium, cervix and thorax in an HIV-negative woman
Authors: Aikaterini Masgala
Constantinos Christopoulos
Niki Giannakou
Haralambos Boukis
Theodora Papadaki
Eleftherios Anevlavis
Publication date: 01-08-2007
Publisher: Springer-Verlag
Published in: Annals of Hematology / Issue 8/2007
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-007-0280-z

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2007

Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas

Kinetics of CXCR-4 and adhesion molecule expression during autologous stem cell mobilisation with G-CSF plus AMD3100 in patients with multiple myeloma

Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution

Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation

Development of a Richter syndrome with a monoclonal component from a true B-cell chronic lymphocytic leukemia (B-CLL) treated with fludarabine

Ifosfamide, epirubicin, and etoposide (IEV) mobilize peripheral blood stem cells more efficiently than cyclophosphamide/etoposide

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials